Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

The catalyst for top weight-loss stocks comes down to one sweeping attribute: a burgeoning total addressable market. According to a Goldman Sachs analysis, earlier last year, the global industry for anti-obesity medications (AOMs) reached $6 billion on an annualized basis. By 2030, the sector could expand by more than 16 times to $100 billion. One…

The post Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks appeared first on InvestorPlace.

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.